BBOTVSERAS• 28 Days (Normalized)
BBOT vs ERAS (BridgeBio Oncology Therapeutics Inc. vs Erasca Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.68%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
ERAS Performance $14.74
-8.96%
Erasca Inc.
Normalized Baseline0.00%
Alpha Spread Margin ERAS LEADS
-47.72 pts
ERAS outperforming by 47.72 percentage points
BBOTERAS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT ERAS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | BBOT Price | BBOT Gain (%) | ERAS Price | ERAS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.68% | $14.74 | -8.96% | -47.72% |
| Sep 30, 2026 | $4.10 | -54.34% | $- | - | |
| Sep 29, 2026 | $3.92 | -56.35% | $- | - | |
| Sep 28, 2026 | $3.81 | -57.57% | $14.13 | -12.72% | -44.85% |
| Sep 25, 2026 | $3.95 | -56.01% | $14.25 | -11.98% | -44.03% |
| Sep 24, 2026 | $3.99 | -55.57% | $14.52 | -10.32% | -45.25% |
| Sep 23, 2026 | $4.16 | -53.67% | $13.95 | -13.87% | -39.80% |
| Sep 22, 2026 | $4.66 | -48.11% | $15.55 | -3.95% | -44.16% |
| Sep 21, 2026 | $4.66 | -48.11% | $15.04 | -7.10% | -41.01% |
| Sep 18, 2026 | $4.77 | -46.88% | $14.77 | -8.77% | -38.11% |
| Sep 17, 2026 | $4.89 | -45.55% | $15.34 | -5.25% | -40.30% |
| Sep 16, 2026 | $4.76 | -46.99% | $15.36 | -5.13% | -41.86% |
| Sep 15, 2026 | $4.88 | -45.66% | $16.25 | +0.37% | -46.03% |
| Sep 14, 2026 | $5.05 | -43.76% | $16.16 | -0.19% | -43.57% |
| Sep 11, 2026 | $4.95 | -44.88% | $15.88 | -1.91% | -42.97% |
Page 1 of 2